JMP Securities Reiterates Market Outperform on MorphoSys, Maintains $17 Price Target
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst Jason Butler has reiterated a 'Market Outperform' rating on MorphoSys (NASDAQ:MOR) and maintained a price target of $17.
November 21, 2023 | 3:55 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JMP Securities analyst reaffirms 'Market Outperform' rating on MorphoSys with a $17 price target, indicating a positive outlook for the stock.
The reiteration of a 'Market Outperform' rating and the maintenance of a $17 price target by a reputable analyst could lead to increased investor confidence in MorphoSys, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100